Skip to content

To Study The Effect Of Navkarshika Kwatha And Varyadi Kashaya In The Management Of Vatarakta (Gouty Arthritis)

A Randomized Comparative Study on the role of Navkarshika Kwatha and Varyadi Kashaya in the management of Vatarakta with Special Reference to Gouty Arthritis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098997
Enrollment
30
Registered
2025-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Sponsors

Jammu Institute of Ayurveda and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects aged between 25 to 60 years of either sex will be selected 2.Subjects presenting with clinical features of vatarakta (gouty arthritis) 3.Serum Uric Acid : -More than 7.0mg/dl in Males -More than 6.0mg/dl in Females 4. Subjects willing to participate with written informed consent, which is conveyed in the language which the subject can understand 5. Chronicity less than 2years

Exclusion criteria

Exclusion criteria: 1.Subjects diagnosed with other inflammatory and degenerative joint diseases 2.Subjects with history of trauma, fractured joint, surgical or diagnostic intervention with reference to the affected joints 3.Subjects having any marked deformity 4. Subjects with any uncontrolled systemic illness including Diabetes Mellitus, Hypertension 5. Pregnant and Lactating woman 6. Chronicity more than 2years

Design outcomes

Primary

MeasureTime frame
Improvement in subjective and objective parameters of Vatarakta : SUBJECTIVE : Sandhishula, Daha, Sandhishotha, Sparshaasahatva, Vaivarnya OBJECTIVE CRITERIA : Serum UricAcid levels, ESR Timepoint: Assessment: Precentage relif in symptoms and signs after 30 days of treatment.

Secondary

MeasureTime frame
1. Change in Serum Uric Acid Levels 2. Change in ESR (Inflammatory Marker) 3. Patient Global Assessment of ImprovementTimepoint: Follow up evaluation at 15th, 30th, & 45th day (including drug free period follow up)

Countries

India

Contacts

Public ContactDr Sambhavi Puri

Jammu Institute Of Ayurveda And Research

sourabh.gupta32@gmail.com9419312498

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026